NCT07115810View on ClinicalTrials.gov

No Prognostic or Molecular Disparity Between Synchronous and Metachronous Metastases in Differentiated Thyroid Cancer: Insight From Middle Eastern Cohort

CompletedOBSERVATIONAL
Enrollment

178

Participants

Timeline

Start Date

January 1, 1988

Primary Completion Date

December 31, 2018

Study Completion Date

December 31, 2024

Conditions
Differentiated Thyroid Cancer
Interventions
OTHER

No additional drugs(control Group)

No intervention

All Listed Sponsors
lead

King Faisal Specialist Hospital & Research Center

OTHER